MDI Health has developed an AI-driven pharmacology platform capable of performing multidimensional context-based analyses of thousands of pharmacological and patient-specific parameters in order to autonomously optimize personal medication regimens across the entire population. The company’s powerful artificial intelligence is used by payers and value-based providers to identify high-risk patients for adverse drug events, to make changes in order to reduce those risks in real time, and to execute the given recommendations, thereby reducing total care costs while improving quality.